Literature DB >> 10559669

Nitric oxide stimulates growth hormone secretion in vitro through a calcium- and cyclic guanosine monophosphate-independent mechanism.

L Pinilla1, M Tena-Sempere, E Aguilar.   

Abstract

In the last years, nitric oxide (NO) has emerged as an important intra- and intercellular transmitter involved in the control of the hypothalamic-pituitary axis, and NO synthase (NOS) has been identified in pituitary cells. To determine the role of NO in the control of GH secretion acting directly at the pituitary level, we have studied GH release by hemipituitaries incubated in the presence of different concentrations (10(-7)-10(-3) M) of sodium nitroprusside (SNP), a potent NO donor. We found that SNP (10(-4)-10(-3) M) stimulated GH release. This effect was mediated by the release of NO since it was abolished in the presence of hemoglobin, a scavenger of NO, but preserved in the presence of rhodanese + sodium thiosulfate (inactivators of cyanides generated from SNP). To analyze the participation of cyclic guanosine monophosphate (cGMP), the second messenger for a wide range of NO actions, in SNP-stimulated GH secretion, hemipituitaries were incubated in the presence of 8-bromo-cGMP (8-Br-cGMP; 10(-7)-10(-3) M). In addition, hemipituitaries were stimulated with SNP plus oxadiazoloquinoxaline (OQD) or LY 83,583 (inhibitors of guanylyl cyclases). We found that 8-Br-cGMP was ineffective in eliciting GH release, and that the stimulatory effect of SNP was maintained in presence of OQD and LY 83,583. Finally, to analyze calcium dependence, the SNP effect was studied in hemipituitaries incubated in free medium calcium, in the presence of nifedipine and verapamil (blockers of calcium channels) and after depletion of intracellular Ca(2+) stores with caffeine. We found that the SNP-induced GH secretion is also detected after incubation of hemipituitaries in free calcium medium, in the presence of nifedipine and verapamil, and after caffeine preincubation. We conclude that NO stimulates GH secretion in vitro through a specific calcium-cGMP-independent mechanism. Copyrightz1999S.KargerAG,Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559669     DOI: 10.1159/000023378

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  11 in total

Review 1.  The exercise-induced growth hormone response in athletes.

Authors:  Richard J Godfrey; Zahra Madgwick; Gregory P Whyte
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons.

Authors:  Jamie Bellamy; Elizabeth J Bowen; Andrew F Russo; Paul L Durham
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

3.  NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP.

Authors:  I L Buxton; R A Kaiser; N A Malmquist; S Tichenor
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

4.  Nitric oxide stimulates growth hormone secretion from human fetal pituitaries and cultured pituitary adenomas.

Authors:  Tami Rubinek; Hadara Rubinfeld; Moshe Hadani; Gad Barkai; Ilan Shimon
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

5.  Signaling pathway networks mined from human pituitary adenoma proteomics data.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2010-04-28       Impact factor: 3.063

6.  Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.

Authors:  Xianquan Zhan; Xiaowei Wang; Ying Long; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2014-12-24       Impact factor: 3.063

7.  The Unexpected Role of Calcium-Activated Potassium Channels: Limitation of NO-Induced Arterial Relaxation.

Authors:  Johannes Schmid; Bettina Müller; David Heppeler; Dina Gaynullina; Mario Kassmann; Hristo Gagov; Mitko Mladenov; Maik Gollasch; Rudolf Schubert
Journal:  J Am Heart Assoc       Date:  2018-03-24       Impact factor: 5.501

8.  Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas.

Authors:  Xianquan Zhan; Jiajia Li; Tian Zhou
Journal:  Front Pharmacol       Date:  2021-03-24       Impact factor: 5.810

9.  The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

Review 10.  Pituitary adenoma nitroproteomics: current status and perspectives.

Authors:  Xianquan Zhan; Xiaowei Wang; Dominic M Desiderio
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.